Search results for "C1"

showing 10 items of 3475 documents

MUCI, glycans and the cell-surface barrier to embryo implantation

2001

As it approaches the maternal surface, the attaching embryo encounters the epithelial glycocalyx, which contains the mucin, MUC1. A high density of MUC1 at the cell surface can inhibit cell adhesion. This raises the possibility of the existence of a uterine barrier to implantation that might allow maternal rejection of poorer quality embryos. To investigate the mechanism of implantation, human embryos were incubated with endometrial epithelial monolayers. Hatched blastocysts were found to attach readily to the epithelial surface. MUC1 was lost from epithelial cells beneath and near to the attached embryo, while normal expression persisted in neighbouring cells.

medicine.medical_specialtyanimal structuresMucinCellEmbryoBiologyEndometriumBiochemistryCell biologyGlycocalyxmedicine.anatomical_structureEndocrinologyInternal medicineembryonic structuresmedicineOviductCell adhesionMUC1Biochemical Society Transactions
researchProduct

Lipid Activates mTORC1 and mTORC2 in the Absorption of Dietary Triglycerides

2018

Mechanistic target of rapamycin (mTOR) senses amino acids; however, its role in lipid metabolism is less established. Organismal lipid requirements are largely met through dietary intake. How nutrient sensing mechanisms in gut interface with dietary fat remains unclear. Here we reveal fundamental and cooperative roles for mTOR complexes 1 and 2 (mTORC1/2) in absorption of dietary triglycerides. Dietary lipid activates mTORC1/2 signaling in gut. Hyperactivating mTORC1 by deleting Tsc1 is sufficient to promote triglyceride absorption and metabolic disease in high fat-fed mice. Conversely, blocking mTORC1/2 by deleting Raptor or Rictor each decreases triglyceride absorption. Loss of Raptor seq…

medicine.medical_specialtybiologyTriglycerideChemistrydigestive oral and skin physiologyHypertriglyceridemiaDietary lipidLipid metabolismmTORC1medicine.diseasemTORC2chemistry.chemical_compoundEndocrinologyInternal medicinemedicinebiology.proteinMechanistic target of rapamycinPI3K/AKT/mTOR pathwaySSRN Electronic Journal
researchProduct

Muscular failure training in conditioninig neuromuscular programs

2010

Many recommendations for designing of resistance training programs are suggested training all the sets to perform until voluntary fatigue with a maximum load selected, situation known as muscular failure. However, recent evidence has emerged that suggest caution in the prescription of training to failure in both, healthy and performance perspective. This review has addressed to this issue and made a collection of literature and a qualitative analysis of this topic. Final conclusion of this study suggest that implementation of the muscular failure resistance training is not recommended in subjects who trained with healthy goals, because it breaks the acceptable risk-benefit ratio in healthy …

medicine.medical_specialtybiologybusiness.industryAthleteseducationResistance trainingPhysical Therapy Sports Therapy and Rehabilitationmuscular fatigueTraining to failurebiology.organism_classificationTraining (civil)Muscular fatigueResistance trainingrecoveryQualitative analysisRecoveryMuscular fatiguePhysical therapyEducación Física y DeportivaMedicineMedical prescriptionresistance traininglcsh:Sports medicinebusinesslcsh:RC1200-1245
researchProduct

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks: An Open-Label Extension Study …

2018

medicine.medical_specialtybiologybusiness.industryC1 Esterase Inhibitor ProteinExtension studymedicine.diseaseC1-inhibitorInternal medicineHereditary angioedemabiology.proteinLong term outcomesMedicineOpen labelbusinessSSRN Electronic Journal
researchProduct

Efficacy of C1-Inhibitor Concentrate (Berinert®) for the Treatment of Cutaneous Attacks of Acute Hereditary Angioedema Compared to Historical Untreat…

2013

medicine.medical_specialtybiologybusiness.industryImmunologyHereditary angioedemabiology.proteinImmunology and AllergyMedicinebusinessmedicine.diseaseDermatologyC1-inhibitorJournal of Allergy and Clinical Immunology
researchProduct

Treatment With Pasteurized C1 Inhibitor Concentrate In Skin Swelling Attacks Of Patients With Hereditary Angioedema

2007

medicine.medical_specialtybiologybusiness.industryImmunologymedicine.diseaseDermatologyC1-inhibitorSurgeryHereditary angioedemamedicinebiology.proteinImmunology and AllergySkin swellingbusinessJournal of Allergy and Clinical Immunology
researchProduct

C1 Inhibitor for Routine Prophylaxis in Patients with Hereditary Angioedema: Interim Results from a European Registry Study

2016

medicine.medical_specialtybiologybusiness.industryRegistry studyImmunologymedicine.diseaseSurgeryC1-inhibitor03 medical and health sciences0302 clinical medicineInternal medicineInterimHereditary angioedemamedicinebiology.proteinImmunology and AllergyIn patient030212 general & internal medicinebusiness030217 neurology & neurosurgeryJournal of Allergy and Clinical Immunology
researchProduct

PGC-1 isoforms and their target genes are expressed differently in human skeletal muscle following resistance and endurance exercise

2015

The primary aim of the present study was to investigate the acute gene expression responses of PGC-1 isoforms and PGC-1a target genes related to mitochondrial biogenesis (cytochrome C), angiogenesis (VEGF-A), and muscle hypertrophy (myostatin), after a resistance or endurance exercise bout. In addition, the study aimed to elucidate whether the expression changes of studied transcripts were linked to phosphorylation of AMPK and MAPK p38. Nineteen physically active men were divided into resistance exercise (RE, n = 11) and endurance exercise (EE, n = 8) groups. RE group performed leg press exercise (10 9 10 RM, 50 min) and EE walked on a treadmill (~80% HRmax, 50 min). Muscle biopsies were ob…

medicine.medical_specialtybiologysplice variantPhysiologyVastus lateralis musclePGC-1αphysical activitySkeletal muscleta3141MyostatinMuscle hypertrophyExonmedicine.anatomical_structureEndocrinologyPGC1-1βMitochondrial biogenesisEndurance trainingPhysiology (medical)Internal medicineGene expressionmedicinebiology.proteinta315Original ResearchPhysiological Reports
researchProduct

Bloodstream infections in intensive care unit patients: Distribution and antibiotic resistance of bacteria

2015

Vincenzo Russotto,1 Andrea Cortegiani,1 Giorgio Graziano,2 Laura Saporito,2 Santi Maurizio Raineri,1 Caterina Mammina,2 Antonino Giarratano1 1Department of Biopathology and Medical Biotechnologies (DIBIMED), Section of Anaesthesia, Analgesia, Intensive Care and Emergency, Paolo Giaccone University Hospital, University of Palermo, Palermo, Italy; 2Department of Sciences for Health Promotion and Mother-Child Care, University of Palermo, Palermo, Italy Abstract: Bloodstream infections (BSIs) are among the leading infections in critically ill patients. The case-fatality rate associated with BSIs in patients admitted to intensive care units (ICUs) reaches 35%–50%. The emergence and diffusi…

medicine.medical_specialtybloodstream infectionsmedicine.drug_classAntibioticsICU; MDR; antibiotic; bloodstream infections; intensive care unit; multidrug resistantSettore MED/41 - AnestesiologiaReviewBloodstream infectionmedicine.disease_causelcsh:Infectious and parasitic diseaseslaw.inventionAntibiotic resistancelawIntensive careEpidemiologyMDRmedicinelcsh:RC109-216Pharmacology (medical)Intensive care unitMED/41 - ANESTESIOLOGIAIntensive care medicinePharmacologybiologybusiness.industryAntibioticAcinetobacterbiology.organism_classificationIntensive care unitMultiple drug resistanceInfectious DiseasesMultidrug resistantStaphylococcus aureusICUAntibiotic; Bloodstream infections; ICU; Intensive care unit; MDR; Multidrug resistantbusiness
researchProduct

Successful Extubation With Use of C1 Esterase Inhibitor Concentrate in a Patient With Hereditary Angioedema: In Response

2000

medicine.medical_specialtybusiness.industryHereditary angioedemaMedicineGeneral Medicinebusinessmedicine.diseaseDermatologyC1 esteraseMayo Clinic Proceedings
researchProduct